Selexipag DPA Des-Isopropyl Impurity
It is a selective IP agonist and first agent targeting a prostanoid receptor that is used for the treatment of pulmonary hypertension (PAH).
Additional information on Selexipag DPA Des-Isopropyl Impurity
2-( 4-((5, 6-Diphenylpyrazine-2-yl)amino)butoxy)acetic acid
Hardin, Elizabeth A., and Kelly Chin. “Selexipag in the Treatment of Pulmonary Arterial Hypertension: Design, Development, and Therapy.” Drug Design, Development and Therapy, vol. Volume 10, Nov. 2016, pp. 3747–54, https://doi.org/10.2147/dddt.s103534. ?
Other products related to selexipag
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|